移植物抗宿主病损害NK细胞依赖性抗白血病与病毒特异性先天免疫
异基因骨髓移植后发生移植物抗宿主病(GVHD)的小鼠模型中,供者T细胞与NK细胞竞争白细胞介素15(IL-15),导致NK细胞重建受损,表现为成熟M1和M2 NK细胞亚群减少、活化/凋亡/自噬过度;给予IL-15/IL-15Rα或雷帕霉素可恢复NK细胞重建;GVHD还导致NK细胞依赖性体内细胞毒作用和移植物抗白血病效应失败,并损害巨细胞病毒感染控制。
要点
- GVHD通过限制IL-15可用性损害NK细胞重建,尤其影响成熟M1和M2亚群。
- IL-15/IL-15Rα或雷帕霉素可恢复GVHD条件下的NK细胞重建。
- GVHD导致NK细胞依赖性体内细胞毒作用、移植物抗白血病效应及巨细胞病毒感染控制受损。
核心结论
- GVHD期间供者T细胞与NK细胞竞争IL-15,诱导NK细胞重建严重缺陷,损害白血病和病原体特异性免疫。
研究设计与样本
- 研究采用异基因骨髓移植(allo-BMT)小鼠模型,观察GVHD对NK细胞重建的影响。
主要发现
- GVHD阻止NK细胞重建,尤其使成熟M1和M2 NK细胞亚群减少,并伴有活化、凋亡和自噬过度。
- 供者T细胞通过限制IL-15可用性在该过程中起关键作用。
- 给予IL-15/IL-15Rα或雷帕霉素免疫抑制可恢复NK细胞重建。
- GVHD诱导的NK细胞缺陷导致NK细胞依赖性体内细胞毒作用和移植物抗白血病效应失败。
- GVHD期间异基因骨髓移植后巨细胞病毒感染控制也受损。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Allogeneic bone marrow transplantation (allo-BMT) is a curative therapy for hematological malignancies, but is associated with significant complications, principally graft-versus-host disease (GVHD) and opportunistic infections. Natural killer (NK) cells mediate important innate immunity that provides a temporal bridge until the reconstruction of adaptive immunity. Here, we show that the development of GVHD after allo-BMT prevented NK-cell reconstitution, particularly within the maturing M1 and M2 NK-cell subsets in association with exaggerated activation, apoptosis, and autophagy. Donor T cells were critical in this process by limiting the availability of interleukin 15 (IL-15), and administration of IL-15/IL-15Rα or immune suppression with rapamycin could restore NK-cell reconstitution. Importantly, the NK-cell defect induced by GVHD resulted in the failure of NK-cell-dependent in vivo cytotoxicity and graft-versus-leukemia effects. Control of cytomegalovirus infection after allo-BMT was also impaired during GVHD. Thus, during GVHD, donor T cells compete with NK cells for IL-15 thereby inducing profound defects in NK-cell reconstitution that compromise both leukemia and pathogen-specific immunity.
引用
- Bunting MD, Varelias A, Souza-Fonseca-Guimaraes F, et al. GVHD prevents NK-cell-dependent leukemia and virus-specific innate immunity. Blood. 2016. PMID: 27927647. doi:10.1182/blood-2016-08-734020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。